CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision

NCT00174616 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Rectal Neoplasms

Interventions

DRUG: Oxaliplatin, capecitabine, radiotherapy

Sponsor

Sanofi